PRPH - Intrinsic Value and Financial Analysis - ProPhase Labs, Inc.

ProPhase Labs, Inc. PRPH

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US

Watchlist

$ 0.75

-0.186 %

$ 17.9 M

Market Cap

-0.51

P/E

BALANCE SHEET

91.9 M ASSETS

Growth Rates

1Year 4.88%

3Years 43.05%

5Years 34.69%

7Years 32.53%

10Years 18.10%

42.5 M LIABILITIES

Growth Rates

1Year 77.14%

3Years 26.84%

5Years 58.65%

7Years 29.84%

10Years 24.32%

49.4 M EQUITY

Growth Rates

1Year -22.39%

3Years 67.25%

5Years 24.51%

7Years 35.26%

10Years 14.64%

BALANCE SHEET DECOMPOSITION

Balance Sheet Decomposition ProPhase Labs, Inc.

91.9 M ASSETS
42.5 M LIABILITIES

Current Assets	47.6 M
Cash & Short-Term Investments	4.74 M
Receivables	36.3 M
Other Current Assets	6.54 M
Non-Current Assets	44.3 M
Long-Term Investments	0
PP&E	17.5 M
Other Non-Current Assets	26.9 M

Current Liabilities	20.9 M
Accounts Payable	9.38 M
Short-Term Debt	2.79 M
Other Current Liabilities	8.68 M
Non-Current Liabilities	21.7 M
Long-Term Debt	18.6 M
Other Non-Current Liabilities	3.1 M

Balance Sheet

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015	Dec-2014	Dec-2013	Dec-2012	Dec-2011	Dec-2010	Dec-2009	Dec-2008	Dec-2007	Dec-2006	Dec-2005	Dec-2004	Dec-2003	Dec-2002	Dec-2001	Dec-2000	Dec-1999	Dec-1998	Dec-1997	Dec-1996
ASSETS
Cash & Cash Equivalents	2.1	9.1	8.4	6.8	0.4	1.6	3.2	0.4	1.7	2.9	1.6	0.6	5.5	8.2	12.8	12.0	16.1	17.8	16.9	14.4	11.4	12.9	9.7	11.4	14.0	28.3	25.5	0.4
Short Term Investments	3.1	8.3	8.9	1.6	0.9	6.7	18.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Receivables	36.3	37.1	37.7	3.2	6.8	7.8	1.9	5.8	4.0	5.8	5.3	5.4	3.2	4.8	2.1	4.5	6.6	6.6	7.9	6.4	7.9	4.2	4.2	4.1	6.6	7.6	10.9	0.6
Inventory	3.8	4.0	4.6	3.0	1.5	1.9	1.5	2.7	4.3	3.3	2.5	2.1	2.7	1.7	1.4	3.0	4.8	4.3	3.9	3.5	3.8	4.5	6.5	6.9	6.2	6.5	7.7	100 K
Other Current Assets	2.7	2.4	1.7	2.5	0.3	0.3	3.0	0.9	1.9	1.4	3.1	5.4	3.5	1.0	0.9	1.2	2.9	1.2	1.6	0.8	0.7	0.9	2.2	1.1	3.9	4.6	5.1	100 K
Total Current Assets	47.6	60.8	61.3	15.9	9.9	18.2	28.9	9.6	11.9	13.5	11.3	10.7	13.2	15.8	17.2	20.7	28.8	29.8	30.2	25.0	23.7	22.5	22.2	23.5	30.7	47.0	49.2	1.0
PP&E	17.5	11.3	10.3	8.3	2.3	2.5	2.7	3.2	3.0	2.6	2.6	2.4	2.3	2.4	2.6	3.7	4.4	4.8	5.6	6.5	2.4	2.3	2.2	2.1	1.9	1.0	0.2	100 K
Intangible Assets	12.3	8.5	10.9	1.2	0	0	0	0	0	0	3.6	3.6	3.6	3.6	0	0	0	0	30.8 K	30.8 K	30.8 K	0	21.9 K	0.4	0.2	0.3	0.4	0.2
Goodwill	5.2	5.7	5.7	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.8 K	0.3	0	0	0	0	0
Long Term Investments	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Long Term Assets	2.0	1.3	1.1	5.1	(2.3)	0	2.5	0	0	0	0	(5.9)	0	0	12 K	35.5 K	0.1	0.2	0.1	63.8 K	80.4 K	91.4 K	24.2 K	7.3 K	0.5	0.3	0	100 K
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	91.9	87.6	89.3	31.4	12.3	20.7	34.2	12.8	14.8	16.1	17.4	16.7	19.1	21.7	19.8	24.4	33.3	34.8	36.0	31.5	26.3	24.9	24.8	26.1	33.3	48.6	49.8	1.4
LIABILITIES
Accounts Payable	9.4	5.9	7.0	3.8	0.4	0.4	0.6	2.2	1.0	0.7	1.0	1.3	0.9	0.5	0.5	0.7	0.5	0.9	0.8	1.0	0.5	0.4	0.8	0.8	0.4	0.8	1.1	100 K
Short Term Debt	2.8	0.6	1.3	0.7	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0	0	0	0
Other Current Liabilities	3.0	2.9	3.8	1.7	0.4	3.5	1.2	3.2	3.5	4.6	3.6	3.6	7.0	7.7	5.3	5.9	9.6	8.4	8.4	5.7	5.0	6.1	2.7	4.1	6.7	3.2	7.0	0
Total Current Liabilities	20.9	16.1	15.5	6.3	0.9	4.2	1.1	6.8	4.5	5.2	4.6	4.9	7.9	8.2	5.8	6.6	10.0	9.3	9.6	7.1	5.5	6.5	3.6	4.8	7.1	4.0	8.1	100 K
Long Term Debt	18.6	6.7	14.2	14.4	0	0	0	0	1.5	0	0	0.3	0	0	0	0	0	0	1.0	2.5	0	0	0	0	0	0	0	0
Deferred Tax Income	0	0.2	10.0	(10.2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	2.0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	100 K
Total Liabilities	42.5	24.0	30.7	20.8	1.0	4.2	1.1	6.8	6.0	5.3	4.8	5.2	7.9	8.2	5.8	6.6	10.0	9.3	10.6	9.6	5.5	6.5	3.6	4.8	7.1	4.0	8.1	0.2
EQUITY
Common Stock	18 K	16 K	16 K	14 K	14 K	14 K	14 K	13 K	13 K	13 K	11 K	11 K	10 K	10 K	9 K	8.78 K	8.75 K	8.66 K	8.18 K	8.14 K	8.07 K	8.05 K	7.66 K	7.64 K	7.4	0	0	0
Retained Earnings	(5.0)	11.8	2.6	(3.6)	(1.5)	4.5	22.1	(19.7)	(16.8)	(13.2)	(5.4)	(5.8)	(4.7)	(2.0)	1.5	5.4	10.9	13.3	15.1	11.9	11.7	11.0	17.5	17.2	22.4	26.6	19.8	(2.8)
Other Accumulative Comprehensive Income/Loss	(0.3)	0.8	(0.2)	11 K	2 K	24 K	78 K	(5.1)	(4.7)	(4.3)	(4.1)	(3.9)	(3.6)	(3.4)	(3.2)	(4.9)	(5.0)	(4.0)	(3.2)	(1.8)	(1.4)	(1.0)	(0.8)	(0.5)	(0.3)	(0.2)	100 K	0
Total Equity	49.4	63.6	58.6	10.6	11.2	16.5	33.1	6.0	8.8	10.7	12.6	11.5	11.2	13.5	14.1	17.8	23.3	25.6	25.4	22.0	20.8	18.4	21.2	21.2	26.2	44.6	41.7	1.2
Total Liabilities and Equity	91.9	87.6	89.3	31.4	12.3	20.7	34.2	12.8	14.8	16.1	17.4	16.7	19.1	21.7	19.8	24.4	33.3	34.8	36.0	31.5	26.3	24.9	24.8	26.1	33.3	48.6	49.8	1.4
SHARES OUTSTANDING
Common Shares Outstanding	17.2	15.8	15.2	11.6	11.6	11.4	15.6	16.7	16.1	16.7	15.8	14.8	14.8	14.3	13.0	12.9	12.7	12.2	11.7	11.5	11.5	10.9	10.7	10.6	11.4	13.3	12.2	4.1

Balance Sheet

Premium Plan

Unlimited Plan